MAPT and Alzheimer disease: The use of natural and synthetic cannabinoids through activation of CBR subtypes in a different model of AD exhibited beneficial effects, including suppression of Aβ induced toxicity, tau phosphorylation, and also involvement in the intrinsic defense mechanism of the brain [327].